55.50SEK-0.18%Mkt Cap: 1.29B SEKP/E: —Last update: 2026-06-01
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized for…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap1.29B SEK
Enterprise Value1.19B SEK
Revenue (TTM)344.91M SEK
Gross Profit208.81M SEK
Net Income (TTM)-16.71M SEK
Revenue/Share14.21 SEK
Last Price55.50 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees143
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)13.56
PEG—
EV/EBITDA41.67
EV/Revenue3.46
P/S3.75
P/B3.19
EPS (TTM)-0.47
EPS (Forward)4.10
52W Range
41.0032% of range85.80
52W High85.80 SEK
52W Low41.00 SEK
Profitability
Gross Margin66.64%
Oper. Margin0.19%
EBITDA Margin8.30%
Profit Margin-5.33%
ROE-4.13%
ROA-3.49%
Growth
Revenue Growth30.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF7.39M SEK
CapEx (TTM)23.47M SEK
FCF Margin-4.40%
FCF Yield-1.17%
Net Debt-101.51M SEK
Net Debt/EBITDA-3.55
Balance Sheet
Debt/Equity0.03
Current Ratio3.74
Quick Ratio3.13
Book Value/Sh17.41 SEK
Cash/Share4.559 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)92.50 SEK
Target Range82.00 SEK – 103.00 SEK
# Analysts2
Ownership
Shares Out.23.27M
Float16.57M
Insiders42.64%
Institutions19.71%
Technical
SMA 5048.76 (+13.8%)
SMA 20056.74 (-2.2%)
Beta0.45
S&P 52W Chg27.70%
Avg Vol (30d)41.03K
Avg Vol (10d)92.93K
Technical Indicators
RSI (14)68.8
MACD1.4103
MACD Signal0.8201
MACD Hist.+0.5902
BB Upper54.78 SEK
BB Middle50.51 SEK
BB Lower46.24 SEK
BB Width16.91%
ATR (14)2.067 SEK
Vol Ratio (20d)0.41x